Journal ArticleOPEN ACCESS

Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease

  • Khurana M
  • Raj S
Open Journal of Blood Diseases (2017) 07(03) 79-85
DOI: 10.4236/ojbd.2017.73008
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Drug-induced immune hemolytic anemia (DIIHA) is commonly attributed to cephalosporins. Ceftriaxone is the most frequently administered cephalosporin in patients with sickle cell disease. We present a pediatric patient with severe DIIHA (hemoglobin

Cite

CITATION STYLE

APA

Khurana, M., & Raj, S. S. (2017). Drug-Induced Hemolytic Anemia: A Fatal Complication Further Under-Recognized in Sickle Cell Disease. Open Journal of Blood Diseases, 07(03), 79–85. https://doi.org/10.4236/ojbd.2017.73008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free